Tom Ellis
About
In The Last Decade
Tom Ellis
13 papers receiving 705 citations
Peers
Comparison fields: 5 of 74
- Surgery 400
- Immunology 255
- Cardiology and Cardiovascular Medicine 95
- Rheumatology 88
- Oncology 77
Countries citing papers authored by Tom Ellis
This map shows the geographic impact of Tom Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Ellis more than expected).
Fields of papers citing papers by Tom Ellis
This network shows the impact of papers produced by Tom Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Ellis. The network helps show where Tom Ellis may publish in the future.
Co-authorship network of co-authors of Tom Ellis
This figure shows the co-authorship network connecting the top 25 collaborators of Tom Ellis. A scholar is included among the top collaborators of Tom Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Ellis. Tom Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 6 | |
| 7 | 366 | |
| 8 | 1 | |
| 9 | 157 | |
| 10 | 70 | |
| 11 | 66 | |
| 12 | Role of recombinant interleukin-2 (rIL-2) and large granular lymphocytes (LGLs) in acute rat graft-versus-host disease (GVHD). | 1 |
| 13 | Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2. | 43 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.